Trade Icosavax, Inc. - ICVX CFD
Add to favourite- Summary
- Historical Data
| Spread | 0.07 | ||||||||
|
Long position overnight fee
Long position overnight fee
Go to platform | -0.026179% | ||||||||
|
Short position overnight fee
Short position overnight fee
Go to platform | 0.003957% | ||||||||
| Overnight fee time | 21:00 (UTC) | ||||||||
| Min traded quantity | 1 | ||||||||
| Currency | USD | ||||||||
| Margin | 5% | ||||||||
| Stock exchange | United States of America | ||||||||
| Commission on trade | 0% |
| Prev. Close | 15.37 |
| Open | 15.34 |
| 1-Year Change | 58.31% |
| Day's Range | 15.25 - 15.37 |
- Last Week
- Last Month
- Last Year
- Last two Years
- Max
- Daily
- Weekly
- Monthly
| Date | Close | Change | Change (%) | Open | High | Low |
|---|---|---|---|---|---|---|
| Feb 16, 2024 | 15.32 | 0.03 | 0.20% | 15.29 | 15.41 | 15.25 |
| Feb 15, 2024 | 15.37 | 0.04 | 0.26% | 15.33 | 15.43 | 15.16 |
| Feb 14, 2024 | 15.31 | -0.16 | -1.03% | 15.47 | 15.53 | 15.31 |
| Feb 13, 2024 | 15.40 | 0.03 | 0.20% | 15.37 | 15.51 | 15.31 |
| Feb 12, 2024 | 15.38 | 0.09 | 0.59% | 15.29 | 15.42 | 15.29 |
| Feb 9, 2024 | 15.30 | 0.06 | 0.39% | 15.24 | 15.39 | 15.24 |
| Feb 8, 2024 | 15.27 | 0.00 | 0.00% | 15.27 | 15.32 | 15.19 |
| Feb 7, 2024 | 15.22 | 0.04 | 0.26% | 15.18 | 15.26 | 15.16 |
| Feb 6, 2024 | 15.21 | 0.04 | 0.26% | 15.17 | 15.21 | 15.16 |
| Feb 5, 2024 | 15.20 | 0.03 | 0.20% | 15.17 | 15.25 | 15.15 |
| Feb 2, 2024 | 15.21 | 0.04 | 0.26% | 15.17 | 15.29 | 15.15 |
| Feb 1, 2024 | 15.18 | -0.09 | -0.59% | 15.27 | 15.28 | 15.14 |
| Jan 31, 2024 | 15.27 | 0.02 | 0.13% | 15.25 | 15.32 | 15.24 |
| Jan 30, 2024 | 15.26 | -0.01 | -0.07% | 15.27 | 15.30 | 15.25 |
| Jan 29, 2024 | 15.29 | 0.05 | 0.33% | 15.24 | 15.34 | 15.24 |
| Jan 26, 2024 | 15.26 | 0.01 | 0.07% | 15.25 | 15.35 | 15.25 |
| Jan 25, 2024 | 15.26 | 0.04 | 0.26% | 15.22 | 15.36 | 15.22 |
| Jan 24, 2024 | 15.27 | 0.05 | 0.33% | 15.22 | 15.36 | 15.17 |
| Jan 23, 2024 | 15.17 | -0.20 | -1.30% | 15.37 | 15.37 | 15.14 |
| Jan 22, 2024 | 15.26 | -0.11 | -0.72% | 15.37 | 15.51 | 15.24 |
Trading calculator
Calculate your hypothetical P&L if you had opened a CFD trade on a certain date (select a date) and closed on a different date (select a date).
- 1:1
- 20
- 100
- 500
- 1000
- 10000
Icosavax, Inc. Company profile
About Icosavax Inc
Icosavax Inc. is a biopharmaceutical company. The Company uses its virus-like particle (VLP) platform technology to develop vaccines against infectious diseases, with a focus on respiratory diseases. Its VLP platform technology is designed to enable multivalent, particle-based display of complex viral antigens. The Company's pipeline includes vaccine candidates targeting viral causes of pneumonia. Its vaccine candidate IVX-A12 is a bivalent candidate, or a mixture of two different VLP candidates. IVX-A12 combines IVX-121, a vaccine candidate designed to target respiratory syncytial virus (RSV), and IVX-241, a vaccine candidate designed to target human metapneumovirus (hMPV). The Company is also developing two severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) vaccine candidates, IVX-411 and IVX-421, with a Phase I/II clinical trial of IVX-411.
Financial summary
BRIEF: For the nine months ended 30 September 2021, Icosavax Inc revenues totaled $5.7M. Net loss totaled to $48.8M.
| Industry: | Biotechnology & Medical Research (NEC) |
1930 Boren Ave., Suite 1000
SEATTLE
WASHINGTON 98101
US
News
We’re partnering with Newsquawk
Filter out the noise and focus on the news that matters.
08:32, 23 April 2024
US Earnings Season: Tesla, Alphabet, Meta Platforms and Microsoft
The first lot of Wall Street’s mega-cap tech companies report in the coming week. We preview what to expect from Tesla, Alphabet, Meta, and Microsoft’s quarterly results.
15:56, 22 April 2024
Gold price in 2024: geopolitical tensions and rate-cut expectations keep XAU/USD supported
Investors are keeping a close eye on gold as the conflict in the Middle East escalates with a possibility of a full-scale regional war in the area.
07:56, 17 April 2024
US Earnings Season : JP Morgan, Citigroup, Wells Fargo
The first major US banks report quarterly earnings on Friday, April 12th, 2024. We preview what to expect from JP Morgan, Citigroup, and Wells Fargo's quarterly numbers.
16:03, 11 April 2024
Reserve Bank of New Zealand Preview: Rates expected to remain on hold as inflation fight continues
The Reserve Bank of New Zealand (RBNZ) meets on Wednesday, April 10, 2024. We preview what to expect from the meeting and its possible impact on the NZD/USD.
09:22, 11 April 2024
US CPI Preview: US inflation expected to grind lower amid fears about sticky prices
US CPI data is released on Wednesday, 10 April. We preview what to expect from the data, how it could influence US Federal Reserve policy, and analyse the NASDAQ (US Tech 100).
15:11, 9 April 2024
How escalating geopolitical tensions are impacting oil markets
The bullish momentum in oil prices remains strong as escalating geopolitical tensions raise concerns about supply.
13:34, 4 April 2024People also watch
Still looking for a broker you can trust?
Join the 610,000+ traders worldwide that chose to trade with Capital.com